Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
3(60%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(4)
Completed(1)

Detailed Status

Recruiting3
Not yet recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

recruiting360%
not_yet_recruiting120%
completed120%

Recent Activity

3 active trials
Showing 5 of 5
recruitingnot_applicable

Cannabis and Processing Emotions Study

NCT06907979
not_yet_recruitingnot_applicable

The PREVENT Resilience Study

NCT07568145
recruitingnot_applicable

Brain Stimulation to the Hippocampus in Schizophrenia

NCT07010614
recruitingnot_applicable

A Combined Neurofeedback-TMS Intervention for Alcohol Use Disorder

NCT05621538
completednot_applicable

Modulation of Sense of Agency With Non-invasive Brain Stimulation and Mindfulness-based Stress Reduction Therapy

NCT05086380

Clinical Trials (5)

Showing 5 of 5 trials
NCT06907979Not Applicable

Cannabis and Processing Emotions Study

Recruiting
NCT07568145Not Applicable

The PREVENT Resilience Study

Not Yet Recruiting
NCT07010614Not Applicable

Brain Stimulation to the Hippocampus in Schizophrenia

Recruiting
NCT05621538Not Applicable

A Combined Neurofeedback-TMS Intervention for Alcohol Use Disorder

Recruiting
NCT05086380Not Applicable

Modulation of Sense of Agency With Non-invasive Brain Stimulation and Mindfulness-based Stress Reduction Therapy

Completed

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5